chr3:66429221:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr3:66,429,221-66,551,446 |
hg38 | chr3:66,378,797-66,501,022 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.003 | renal cell carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | colorectal carcinoma | LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic... | BeFree | 26159916 | Detail |
<0.001 | Colorectal Neoplasms | NA | BeFree | Detail | |
<0.001 | glioblastoma | NA | BeFree | Detail | |
0.003 | Glioma | LRIG1 enhances chemosensitivity by modulating BCL-2 expression and receptor tyro... | BeFree | 25048475 | Detail |
0.003 | Glioma | The soluble LRIG1 ectodomain is demonstrated to be shed naturally and inhibit th... | BeFree | 25353163 | Detail |
0.003 | Glioma | MiR-20a mediated TMZ-resistance in glioblastoma cells through negatively regulat... | BeFree | 25960225 | Detail |
0.003 | Glioma | In the single-locus analysis, six single-nucleotide polymorphisms [ERCC1 3' untr... | BeFree | 19124499 | Detail |
<0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
<0.001 | oligodendroglioma | In oligodendroglioma, LRIG2 expression is associated with poor survival, suggest... | BeFree | 25353163 | Detail |
<0.001 | ovarian carcinoma | NA | BeFree | Detail | |
<0.001 | Skin Neoplasms | Interestingly, the adnexal SC marker Lrig1 was upregulated in SCLTs, showing tha... | BeFree | 25659584 | Detail |
0.002 | Tobacco use disorder | NA | GAD | Detail | |
0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Epithelial hyperplasia of skin | NA | BeFree | Detail | |
<0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | anaplastic oligodendroglioma | In oligodendroglioma, LRIG2 expression is associated with poor survival, suggest... | BeFree | 25353163 | Detail |
<0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
<0.001 | endometrial carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
0.001 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
0.001 | breast carcinoma | NA | BeFree | Detail | |
0.001 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Carcinoma of bladder | Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder ca... | BeFree | 25695283 | Detail |
<0.001 | Well Differentiated Oligodendroglioma | In oligodendroglioma, LRIG2 expression is associated with poor survival, suggest... | BeFree | 25353163 | Detail |
<0.001 | Rhabdoid Tumor of the Kidney | These results demonstrated that LRIG1 can improve chemosensitivity by modulating... | BeFree | 25048475 | Detail |
<0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
0.006 | Mammary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | colorectal cancer | LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic... | BeFree | 26159916 | Detail |
<0.001 | Glioblastoma multiforme | Here, we aimed to elucidate the relationship between miR-20a, its predicted targ... | BeFree | 25960225 | Detail |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | uterine corpus cancer | NA | BeFree | Detail | |
<0.001 | Nasopharyngeal carcinoma | In early stage breast cancer, LRIG1 copy number was recently shown to predict ea... | BeFree | 25180912 | Detail |
<0.001 | adenoma | NA | BeFree | Detail | |
<0.001 | Astrocytoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of urinary bladder | Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder ca... | BeFree | 25695283 | Detail |
0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in co... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LRIG1 enhances chemosensitivity by modulating BCL-2 expression and receptor tyrosine kinase signalin... | DisGeNET | Detail |
The soluble LRIG1 ectodomain is demonstrated to be shed naturally and inhibit the progression of gli... | DisGeNET | Detail |
MiR-20a mediated TMZ-resistance in glioblastoma cells through negatively regulating LRIG1 expression... | DisGeNET | Detail |
In the single-locus analysis, six single-nucleotide polymorphisms [ERCC1 3' untranslated region (UTR... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In oligodendroglioma, LRIG2 expression is associated with poor survival, suggesting that LRIG2 might... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interestingly, the adnexal SC marker Lrig1 was upregulated in SCLTs, showing that active Rac1 leads ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In oligodendroglioma, LRIG2 expression is associated with poor survival, suggesting that LRIG2 might... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cispla... | DisGeNET | Detail |
In oligodendroglioma, LRIG2 expression is associated with poor survival, suggesting that LRIG2 might... | DisGeNET | Detail |
These results demonstrated that LRIG1 can improve chemosensitivity by modulating BCL-2 expression an... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in co... | DisGeNET | Detail |
Here, we aimed to elucidate the relationship between miR-20a, its predicted target genes leucine-ric... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In early stage breast cancer, LRIG1 copy number was recently shown to predict early and late relapse... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cispla... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386526551 dbSNP
- Genome
- hg19
- Position
- chr3:66,429,221-66,551,446
- Variant Type
- snv
Genome browser